Tina Vu
Psychiatry · Frisco, TXNPI 1831659135
Payments from drug & device makers
Across 231 payments — averaging $19.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Corium, LLC$648
- Johnson & Johnson$605
- AbbVie$554
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$489
- Lundbeck LLC$391
- Teva Pharmaceuticals USA, Inc.$372
- plus $1K from 16 others
What the payments were for
- Food & beverage$4,479100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Corium, LLC | 27 | $648 |
| Johnson & Johnson | 32 | $605 |
| AbbVie | 32 | $554 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 25 | $489 |
| Lundbeck LLC | 20 | $391 |
| Teva Pharmaceuticals USA, Inc. | 23 | $372 |
| Axsome Therapeutics, Inc. | 11 | $354 |
| Collegium Pharmaceutical, Inc. | 19 | $289 |
| Noven Therapeutics, LLC | 8 | $167 |
| Otsuka America Pharmaceutical, Inc. | 8 | $147 |
| Ironshore Pharmaceuticals Inc. | 6 | $106 |
| Almatica Pharma LLC | 4 | $72 |
| Harmony Biosciences LLC | 3 | $59 |
| E.r. Squibb & Sons, L.L.C. | 3 | $57 |
| Vertical Pharmaceuticals, LLC | 3 | $56 |
| Noven Pharmaceuticals, Inc. | 1 | $20 |
| Indivior Inc. | 1 | $18 |
| Tempus AI, Inc | 1 | $18 |
| Neos Therapeutics, LP | 1 | $15 |
| GSK | 1 | $15 |
| Bausch Health US, LLC | 1 | $14 |
| Supernus Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,479 in reported general payments places this provider in the 85th percentile of 2,238 psychiatry providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 19 | $642 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Frisco
- Writtika RoyFrisco$1.3M
- Scott BartleyDallas$42.7M
- David BrownAustin$15.8M
- Rajinder ShiwachDesoto$15.4M
- Darin OkudaDallas$14.7M
- Jason MensahBeaumont$10.3M
- Michael DowningDallas$7.6M
- Rakesh JainLake Jackson$7.2M
- Suresh SureddiPlano$5.9M
- Marshall LucasThe Woodlands$4.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.